JRoon, that may be true but the more adoption the better..... as we know, if you find something that works for you, you'll tell two friends and they'll tell two friends and maybe those friends are influencers of some kind......I long for the day when a bunch of us posters can meet up and celebrate a huge windfall as a result of weathering this AMRN saga...... it could happen :-) Eternal optimism abounds.
You are correct. The revenue outside of the USA is joke and will never make up for the lost USA revenue. Once again it appears DU really did do this compny in. I guess maybe AMRN was way off base is just how much revenue could be generated in the rest of the world and that includes Denner. The only real hope is just get the approvals in Italy, France, and China and sell this thing to a BP who might be willing to buy it and has far more experience overseas. AMRN is never ever going to make a profit on its own in Europe while the USA declines so the current path is not sustainable imo.
JR. Actually the Aussies ( its Aussies Capt ) will likely take to Vascepa more than Canadians ...especially at $32 ? co pay . The reason ...It allows them to justify their steak and eggs for breakfast routine ......no worries about a cholesterol clogging heart attack Mate ...I'll just pop me some Vascepa
Market Data 
Markets 
AI
